Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
Smolenschi C, Rassy E, Pallud J, Dezamis E, Copaciu R, Parker F, Garcia G, Lezghed N, Colomba E, Khettab M, Ammari S, Fekhi M, Martanovschi L, Benadhou L, Knafo S, Guyon D, Cheaib B, Dhermain F, Dumont SN.
Smolenschi C, et al. Among authors: cheaib b.
J Neurol. 2023 May;270(5):2702-2714. doi: 10.1007/s00415-023-11600-w. Epub 2023 Feb 22.
J Neurol. 2023.
PMID: 36813928